A Positive ctDNA Test after Adjuvant Therapy: 2023 Best of GI

(1:51)

About Signatera and ctDNA

(1:39)

Understand ctDNA Testing

(3:25)

Axel Grothey, MD | What is Signatera?

(1:43)

ctDNA assay for detection of recurrent disease in patients with early-stage breast cancer

(1:36)

Gregory Botta, MD, PhD | What is Signatera?

(1:30)

Introducing Signatera, a personalized, tumor-informed test

(2:19)

ctDNA in Breast Cancer | 2023 COEDS Discussion Series Fort Lauderdale

(16:11)

Circulating Tumor DNA Tests for Early Stage Cancer Diagnosis

(3:42)

Farshid Dayyani, MD | What is Signatera?

(2:1econd)

Natera Signatera Product Theater at SABCS 2022: The Cycle of ctDNA

(1:46)

Signatera - A New Blood Test to Detect Cancer

(55)

NEW CANCER DISCOVERY - Simple Blood Test to Detect Cancer (ctDNA)

(11:47)

Introducing Signatera, a personalized, tumor-informed test

(38)

John Marshall, MD | What is Signatera?

(48)

ctDNA for Patients with Breast Cancer

(2:1econd)

ctDNA as a biomarker for post-resection colorectal cancer recurrence

(1:19)

Signatera for immunotherapy response monitoring

(2:22)

Arturo Loaiza-Bonilla, MD | What is Signatera?

(2:33)

Circulating Tumor DNA in Breast Cancer and New Data from the San Antonio Breast Cancer Symposium

(4:)